DAL, M. Et Al. 2016. IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?. 7th International Eurasian Hematology Congress , (İstanbul, Turkey).

DAL, M., Karakus, A., CAKAR, M., ULU, B., Hattapoglu, E., Ekmen, M., ... Ulas, T.(2016). IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS? . 7th International Eurasian Hematology Congress, İstanbul, Turkey

DAL, M. Et Al. "IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?," 7th International Eurasian Hematology Congress, İstanbul, Turkey, 2016

DAL, M. Et Al. "IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?." 7th International Eurasian Hematology Congress , İstanbul, Turkey, 2016

DAL, M. Et Al. (2016) . "IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?." 7th International Eurasian Hematology Congress , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={M. DAL Et Al. }, title={IS THE ELTROMPOBAG TREATMENT SAFE OR EFFECTIVE FOR REFRACTORY CHRONIC IMMUNE THROMBOCYTOPENIA PATIENTS?}, congress name={7th International Eurasian Hematology Congress}, city={İstanbul}, country={Turkey}, year={2016}}